Treatment of connective tissue diseases of the skin
AssigneeAstion Development A/S
InventorMorten Weidner
Life of this patent
Estimating the term…
Abstract
The present invention provides effective and safe medicaments for the treatment of connective tissue diseases of the skin, particularly with respect to the treatment of cutaneous forms of Lupus Erythematous. The medicaments comprise as the therapeutically active ingredient a beta2 adrenoceptor agonist. The invention furthermore relates to dermatological compositions without skin sensitization properties and which contain enantiomerically pure or enriched R-enantiomers of a beta2 adrenoceptor agonist.
Claims37
A method for treating a connective tissue disease affecting the skin comprising administering a therapeutically effective amount of a beta2-adrenoceptor agonist to an individual in need thereof.
The method according to 1, with the proviso that the medicament does not further contain a substantial amount of an anti-histamine, Ibudilast or a related compound, a selective serotonin reuptake inhibitor (SSRI) and a non-steroidal immunophilin-dependent immunosuppressant (NsIDI).
The composition according to claim26, wherein the beta2-adrenoceptor agonist is in an amount ranging between 0.2 and 2.5% by weight.
Dependencies are inferred from the claim text.